Autoantigen specificity is associated with clinical presentation: anti-MPO antibodies are identified in around 60% of patients with MPA and 20% of patients with GPA, while anti-PR3 antibodies are reported in around 75% of patients with GPA and 25% of patients with MPA [3]. Here, PRTN3 is linked to microscopic polyangiitis.